These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 25526031)
1. Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype. Beider K; Bitner H; Leiba M; Gutwein O; Koren-Michowitz M; Ostrovsky O; Abraham M; Wald H; Galun E; Peled A; Nagler A Oncotarget; 2014 Nov; 5(22):11283-96. PubMed ID: 25526031 [TBL] [Abstract][Full Text] [Related]
2. CXCL12/CXCR4 pathway orchestrates CSC-like properties by CAF recruited tumor associated macrophage in OSCC. Li X; Bu W; Meng L; Liu X; Wang S; Jiang L; Ren M; Fan Y; Sun H Exp Cell Res; 2019 May; 378(2):131-138. PubMed ID: 30857971 [TBL] [Abstract][Full Text] [Related]
3. CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway. Wu D; Guo X; Su J; Chen R; Berenzon D; Guthold M; Bonin K; Zhao W; Zhou X Biochim Biophys Acta; 2015 Feb; 1853(2):338-47. PubMed ID: 25450979 [TBL] [Abstract][Full Text] [Related]
4. JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression. Chen H; Li M; Sanchez E; Soof CM; Bujarski S; Ng N; Cao J; Hekmati T; Zahab B; Nosrati JD; Wen M; Wang CS; Tang G; Xu N; Spektor TM; Berenson JR Br J Haematol; 2020 Jan; 188(2):283-294. PubMed ID: 31423579 [TBL] [Abstract][Full Text] [Related]
5. Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7. Chatterjee M; von Ungern-Sternberg SN; Seizer P; Schlegel F; Büttcher M; Sindhu NA; Müller S; Mack A; Gawaz M Cell Death Dis; 2015 Nov; 6(11):e1989. PubMed ID: 26583329 [TBL] [Abstract][Full Text] [Related]
6. Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia. van den Berk LC; van der Veer A; Willemse ME; Theeuwes MJ; Luijendijk MW; Tong WH; van der Sluis IM; Pieters R; den Boer ML Br J Haematol; 2014 Jul; 166(2):240-9. PubMed ID: 24697337 [TBL] [Abstract][Full Text] [Related]
7. CXCL12/CXCR4 Mediates Orthodontic Root Resorption via Regulating the M1/M2 Ratio. Fang XY; Zhan YX; Zhou XM; Wu LN; Lin J; Yi YT; Jiang CM; Wang J; Liu J J Dent Res; 2022 May; 101(5):569-579. PubMed ID: 34847760 [TBL] [Abstract][Full Text] [Related]
8. HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization. Tang C; Lei X; Xiong L; Hu Z; Tang B Cell Death Dis; 2021 Apr; 12(5):422. PubMed ID: 33927188 [TBL] [Abstract][Full Text] [Related]
9. HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1. Vandyke K; Zeissig MN; Hewett DR; Martin SK; Mrozik KM; Cheong CM; Diamond P; To LB; Gronthos S; Peet DJ; Croucher PI; Zannettino ACW Cancer Res; 2017 Oct; 77(20):5452-5463. PubMed ID: 28855206 [TBL] [Abstract][Full Text] [Related]
10. Targeting SDF-1 in multiple myeloma tumor microenvironment. Bouyssou JM; Ghobrial IM; Roccaro AM Cancer Lett; 2016 Sep; 380(1):315-8. PubMed ID: 26655999 [TBL] [Abstract][Full Text] [Related]
11. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies. Peled A; Klein S; Beider K; Burger JA; Abraham M Cytokine; 2018 Sep; 109():11-16. PubMed ID: 29903571 [TBL] [Abstract][Full Text] [Related]
12. Trophoblast-derived chemokine CXCL12 promotes CXCR4 expression and invasion of human first-trimester decidual stromal cells. Ren L; Liu YQ; Zhou WH; Zhang YZ Hum Reprod; 2012 Feb; 27(2):366-74. PubMed ID: 22114110 [TBL] [Abstract][Full Text] [Related]
13. Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1. Mirandola L; Apicella L; Colombo M; Yu Y; Berta DG; Platonova N; Lazzari E; Lancellotti M; Bulfamante G; Cobos E; Chiriva-Internati M; Chiaramonte R Leukemia; 2013 Jul; 27(7):1558-66. PubMed ID: 23354012 [TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways. He M; Yu W; Chang C; Miyamoto H; Liu X; Jiang K; Yeh S Mol Oncol; 2020 Aug; 14(8):1779-1799. PubMed ID: 32356397 [TBL] [Abstract][Full Text] [Related]
15. The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma. Mazur G; Gębura K; Gieryng A; Butrym A; Wróbel T; Bogunia-Kubik K Cytokine; 2013 Oct; 64(1):422-6. PubMed ID: 23711392 [TBL] [Abstract][Full Text] [Related]
16. Thalidomide treatment down-regulates SDF-1alpha and CXCR4 expression in multiple myeloma patients. Oliveira AM; Maria DA; Metzger M; Linardi C; Giorgi RR; Moura F; Martinez GA; Bydlowski SP; Novak EM Leuk Res; 2009 Jul; 33(7):970-3. PubMed ID: 18976811 [TBL] [Abstract][Full Text] [Related]
17. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis. Tanegashima K; Suzuki K; Nakayama Y; Tsuji K; Shigenaga A; Otaka A; Hara T FEBS Lett; 2013 Jun; 587(12):1731-5. PubMed ID: 23669361 [TBL] [Abstract][Full Text] [Related]
18. Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia. Ho TK; Tsui J; Xu S; Leoni P; Abraham DJ; Baker DM J Vasc Surg; 2010 Mar; 51(3):689-99. PubMed ID: 20206813 [TBL] [Abstract][Full Text] [Related]
20. CXCL12/CXCR4 axis promotes mesenchymal stem cell mobilization to burn wounds and contributes to wound repair. Hu C; Yong X; Li C; Lü M; Liu D; Chen L; Hu J; Teng M; Zhang D; Fan Y; Liang G J Surg Res; 2013 Jul; 183(1):427-34. PubMed ID: 23462453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]